Approvals/TGA/SIMPONI golimumab (rmc) 50 mg/4 mL concentrate for solution for infusion vial

Approved

STANDARD

SIMPONI golimumab (rmc) 50 mg/4 mL concentrate for solution for infusion vial

Janssen-Cilag Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 358831d09d2b51a0
Product Name: SIMPONI golimumab (rmc) 50 mg/4 mL concentrate for solution for infusion vial
Artg Id: 311990
Artg Name: SIMPONI golimumab (rmc) 50 mg/4 mL concentrate for solution for infusion vial
Sponsor: Janssen-Cilag Pty Ltd
Company Detail Path: /organization/janssen-cilag-pty-ltd
Artg Date: 2019-11-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/9c345edf04595b0b487c5b9191bdc7fd.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1c19850e951d955961df68370dffc53a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

358831d09d2b51a0

Type

Standard